Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product

  2.3.2 Market Size By Technique

  2.3.3 Market Size By Transplant Type

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Product performance & diagnostic efficiency metrics

4.1.1 Share (%) of market by product (reagents & consumables, instruments, software & services).

4.1.2 Improvement (%) in diagnostic accuracy, turnaround time, and workflow efficiency.

4.1.3 Reduction (%) in testing errors and operational delays.

4.2 Technique performance & analytical accuracy metrics

4.2.1 Share (%) of usage by technique (molecular assay, non-molecular assay).

4.2.2 Improvement (%) in sensitivity, specificity, and detection capabilities.

4.2.3 Reduction (%) in false positives and false negatives.

4.3 Transplant type analysis & clinical outcome metrics

4.3.1 Share (%) of demand by transplant type (solid organ transplant, stem cell/bone marrow transplant).

4.3.2 Improvement (%) in graft survival rates and transplant success outcomes.

4.3.3 Reduction (%) in rejection rates and post-transplant complications.

4.4 Clinical efficiency & patient management metrics

4.4.1 Improvement (%) in patient monitoring, donor-recipient matching, and treatment planning.

4.4.2 Reduction (%) in diagnostic turnaround time and hospital stay duration.

4.4.3 Growth (%) in adoption driven by increasing transplant procedures and advanced diagnostic technologies.

5. Transplant Diagnostics Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Reagents & Consumables

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2021 – 2032

 5.3 Instruments

 5.4 Software & Services

6. Transplant Diagnostics Market Segmental Analysis & Forecast, By Technique, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Molecular Assay

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2021 – 2032

 6.3 Non-Molecular Assay

7. Transplant Diagnostics Market Segmental Analysis & Forecast, By Transplant Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Solid Organ Transplant [Kidney, Liver, Heart, Lung]

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2021 – 2032

 7.3 Stem Cell/Bone Marrow Transplant

8. Transplant Diagnostics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Transplant Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.2.3 Transplant Diagnostics Market Size & Forecast, By Technique, 2022–2035

 8.2.4 Transplant Diagnostics Market Size & Forecast, By Transplant Type, 2022–2035

 8.2.5 Transplant Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Transplant Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.3.3 Transplant Diagnostics Market Size & Forecast, By Technique, 2022–2035

 8.3.4 Transplant Diagnostics Market Size & Forecast, By Transplant Type, 2022–2035

 8.3.5 Transplant Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Transplant Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.4.3 Transplant Diagnostics Market Size & Forecast, By Technique, 2022–2035

 8.4.4 Transplant Diagnostics Market Size & Forecast, By Transplant Type, 2022–2035

 8.4.5 Transplant Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Transplant Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.5.3 Transplant Diagnostics Market Size & Forecast, By Technique, 2022–2035

 8.5.4 Transplant Diagnostics Market Size & Forecast, By Transplant Type, 2022–2035

 8.5.5 Transplant Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Transplant Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.6.3 Transplant Diagnostics Market Size & Forecast, By Technique, 2022–2035

 8.6.4 Transplant Diagnostics Market Size & Forecast, By Transplant Type, 2022–2035

 8.6.5 Transplant Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 Egypt

  8.6.5.5 South Africa

  8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 CareDx Inc.

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Thermo Fisher Scientific Inc.

9.6.3 Bio-Rad Laboratories Inc.

9.6.4 Immucor Inc.

9.6.5 Luminex Corporation

9.6.6 Bio-Techne Corporation

9.6.7 F. Hoffmann-La Roche AG

9.6.8 Abbott Laboratories

9.6.9 Illumina Inc.

9.6.10 Pacific Biosciences (PacBio)

9.6.11 GenDx BV

9.6.12 Inno-Train Diagnostik GmbH

9.6.13 Grifols SA

9.6.14 Transmedics Group Inc.

9.6.15 Beckman Coulter Life Sciences

9.6.16 QIAGEN NV

9.6.17 Miltenyi Biotec GmbH

9.6.18 Hemacare Corporation

9.6.19 Hologic Inc.

9.6.20 Agena Bioscience Inc.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures